Table of Content

1 Study Coverage
1.1 Valsartan Drug Product Introduction
1.2 Market by Type
1.2.1 Global Valsartan Drug Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
1.3 Market by Application
1.3.1 Global Valsartan Drug Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
1.4 Global Valsartan Drug Market by Region
1.4.1 Global Valsartan Drug Market by Region: 2018 VS 2023 VS 2029
1.4.2 Global Valsartan Drug Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Valsartan Drug Revenue by Players
2.1.1 Global Valsartan Drug Revenue by Players (2018-2023)
2.1.2 Global Valsartan Drug Revenue Market Share by Players (2018-2023)
2.1.3 Global Top 5 and Top 10 Companies by Valsartan Drug Revenue in 2023
2.2 Global Valsartan Drug Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Valsartan Drug Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Novartis
3.1.1 Novartis Information
3.1.2 Novartis Overview
3.1.3 Novartis Valsartan Drug Revenue and Gross Margin (2018-2023)
3.1.4 Novartis Related Developments
3.2 Sun Pharmaceutical
3.2.1 Sun Pharmaceutical Information
3.2.2 Sun Pharmaceutical Overview
3.2.3 Sun Pharmaceutical Valsartan Drug Revenue and Gross Margin (2018-2023)
3.2.4 Sun Pharmaceutical Related Developments
3.3 Teva
3.3.1 Teva Information
3.3.2 Teva Overview
3.3.3 Teva Valsartan Drug Revenue and Gross Margin (2018-2023)
3.3.4 Teva Related Developments
3.4 Mylan
3.4.1 Mylan Information
3.4.2 Mylan Overview
3.4.3 Mylan Valsartan Drug Revenue and Gross Margin (2018-2023)
3.4.4 Mylan Related Developments
3.5 Alembic Pharmaceuticals
3.5.1 Alembic Pharmaceuticals Information
3.5.2 Alembic Pharmaceuticals Overview
3.5.3 Alembic Pharmaceuticals Valsartan Drug Revenue and Gross Margin (2018-2023)
3.5.4 Alembic Pharmaceuticals Related Developments
3.6 Lupin
3.6.1 Lupin Information
3.6.2 Lupin Overview
3.6.3 Lupin Valsartan Drug Revenue and Gross Margin (2018-2023)
3.6.4 Lupin Related Developments
3.7 Aurobindo Pharma
3.7.1 Aurobindo Pharma Information
3.7.2 Aurobindo Pharma Overview
3.7.3 Aurobindo Pharma Valsartan Drug Revenue and Gross Margin (2018-2023)
3.7.4 Aurobindo Pharma Related Developments
3.8 Macleods Pharmaceuticals
3.8.1 Macleods Pharmaceuticals Information
3.8.2 Macleods Pharmaceuticals Overview
3.8.3 Macleods Pharmaceuticals Valsartan Drug Revenue and Gross Margin (2018-2023)
3.8.4 Macleods Pharmaceuticals Related Developments
3.9 HETERO
3.9.1 HETERO Information
3.9.2 HETERO Overview
3.9.3 HETERO Valsartan Drug Revenue and Gross Margin (2018-2023)
3.9.4 HETERO Related Developments
3.10 Torrent Pharmaceuticals
3.10.1 Torrent Pharmaceuticals Information
3.10.2 Torrent Pharmaceuticals Overview
3.10.3 Torrent Pharmaceuticals Valsartan Drug Revenue and Gross Margin (2018-2023)
3.10.4 Torrent Pharmaceuticals Related Developments
3.11 Huaren Pharmaceutical
3.11.1 Huaren Pharmaceutical Information
3.11.2 Huaren Pharmaceutical Overview
3.11.3 Huaren Pharmaceutical Valsartan Drug Revenue and Gross Margin (2018-2023)
3.11.4 Huaren Pharmaceutical Related Developments
3.12 Jubilant Pharma
3.12.1 Jubilant Pharma Information
3.12.2 Jubilant Pharma Overview
3.12.3 Jubilant Pharma Valsartan Drug Revenue and Gross Margin (2018-2023)
3.12.4 Jubilant Pharma Related Developments
3.13 Amneal Pharmaceuticals
3.13.1 Amneal Pharmaceuticals Information
3.13.2 Amneal Pharmaceuticals Overview
3.13.3 Amneal Pharmaceuticals Valsartan Drug Revenue and Gross Margin (2018-2023)
3.13.4 Amneal Pharmaceuticals Related Developments
3.14 Zhejiang Huahai Pharmaceutical
3.14.1 Zhejiang Huahai Pharmaceutical Information
3.14.2 Zhejiang Huahai Pharmaceutical Overview
3.14.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Revenue and Gross Margin (2018-2023)
3.14.4 Zhejiang Huahai Pharmaceutical Related Developments
3.15 Square Pharmaceuticals
3.15.1 Square Pharmaceuticals Information
3.15.2 Square Pharmaceuticals Overview
3.15.3 Square Pharmaceuticals Valsartan Drug Revenue and Gross Margin (2018-2023)
3.15.4 Square Pharmaceuticals Related Developments
3.16 Unichem Laboratories
3.16.1 Unichem Laboratories Information
3.16.2 Unichem Laboratories Overview
3.16.3 Unichem Laboratories Valsartan Drug Revenue and Gross Margin (2018-2023)
3.16.4 Unichem Laboratories Related Developments
4 Global Valsartan Drug Market Insights
4.1 Global Valsartan Drug Market Revenue 2018-2023
4.2 Global Valsartan Drug Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Valsartan Drug Revenue by Type
5.2 Global Valsartan Drug Market Size Growth by Type 2018-2023
6 Market Size by Application
6.1 Global Valsartan Drug Revenue by Application
6.2 Global Valsartan Drug Market Size Growth by Application 2018-2023
7 Americas
7.1 Americas Valsartan Drug Market Size by Type
7.1.1 Americas Valsartan Drug Revenue by Type (2018-2023)
7.1.2 Americas Valsartan Drug Revenue Share by Type (2018-2023)
7.2 Americas Valsartan Drug Market Size by Application
7.2.1 Americas Valsartan Drug Revenue by Application (2018-2023)
7.2.2 Americas Valsartan Drug Revenue Share by Application (2018-2023)
7.3 Americas Valsartan Drug Market Size by Country
7.3.1 Americas Valsartan Drug Revenue by Country (2018-2023)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Valsartan Drug Market Size by Type
8.1.1 Europe Valsartan Drug Revenue by Type (2018-2023)
8.1.2 Europe Valsartan Drug Revenue Share by Type (2018-2023)
8.2 Europe Valsartan Drug Market Size by Application
8.2.1 Europe Valsartan Drug Revenue by Application (2018-2023)
8.2.2 Europe Valsartan Drug Revenue Share by Application (2018-2023)
8.3 Europe Valsartan Drug Market Size by Country
8.3.1 Europe Valsartan Drug Revenue by Country (2018-2023)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Valsartan Drug Market Size by Type
9.1.1 Asia Pacific Valsartan Drug Revenue by Type (2018-2023)
9.1.2 Asia Pacific Valsartan Drug Revenue Share by Type (2018-2023)
9.2 Asia Pacific Valsartan Drug Market Size by Application
9.2.1 Asia Pacific Valsartan Drug Revenue by Application (2018-2023)
9.2.2 Asia Pacific Valsartan Drug Revenue Share by Application (2018-2023)
9.3 Asia Pacific Valsartan Drug Market Size by Region
9.3.1 Asia Pacific Valsartan Drug Revenue by Region (2018-2023)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Valsartan Drug Market Size by Type
10.1.1 Middle East and Africa Valsartan Drug Revenue by Type (2018-2023)
10.1.2 Middle East and Africa Valsartan Drug Revenue Share by Type (2018-2023)
10.2 Middle East and Africa Valsartan Drug Market Size by Application
10.2.1 Middle East and Africa Valsartan Drug Revenue by Application (2018-2023)
10.2.2 Middle East and Africa Valsartan Drug Revenue Share by Application (2018-2023)
10.3 Middle East and Africa Valsartan Drug Market Size by Country
10.3.1 Middle East and Africa Valsartan Drug Revenue by Country (2018-2023)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Valsartan Drug Industry Trends
11.2 Valsartan Drug Market Drivers
11.3 Valsartan Drug Market Challenges
11.4 Valsartan Drug Market Restraints
12 Valsartan Drug Forecasted Market Size by Type
12.1 Global Valsartan Drug Forecasted Revenue by Type
12.2 Global Valsartan Drug Forecasted Market Size Growth by Type 2023-2029
13 Valsartan Drug Forecasted Market Size by Application
13.1 Global Valsartan Drug Forecasted Revenue by Application
13.2 Global Valsartan Drug Forecasted Market Size Growth by Application 2023-2029
14 Global Valsartan Drug Market Forecasts
14.1 Global Valsartan Drug Market Revenue Forecasts 2023-2029
14.2 Global Valsartan Drug Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Valsartan Drug Forecasts Revenue by Country (2018-2023)
14.4 Europe
14.4.1 Europe Valsartan Drug Forecasts Revenue by Country (2018-2023)
14.5 Asia-Pacific
14.5.1 Asia Pacific Valsartan Drug Forecasts Revenue by Country (2018-2023)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Valsartan Drug Forecasts Revenue by Country (2018-2023)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer